Fund
Forbion
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 5
- Lead
- 3
- New entries
- 1
- Follow ons
- 1
- Latest operation
- 16 September 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 16 Sept | United States, Biotech | Series C | 123 M$ | Lead |
| 09 Sept | United States, Biotech | Series A | 225 M$ | Participant |
| 05 Aug | United States, Biotech | Series B | 115 M$ | Existing investor |
| 28 Apr | Belgium, Biotech | Series A | 125 M$ | Lead |
| 07 Jan | United States, Biotech | Series A | 80 M$ | Lead |
Co investors 18 funds crossed
- Novo Holdings 2 operations
- Sofinnova Investments 2 operations
- Balyasny Asset Management 1 operation
- Canaan Partners 1 operation
- Finchley Healthcare Ventures 1 operation
- Galapagos 1 operation
- General Atlantic 1 operation
- Longwood Fund 1 operation
- Luma Group 1 operation
- Population Health Partners 1 operation
- RA Capital 1 operation
- RA Capital Management 1 operation
- Regeneron Ventures 1 operation
- Samsara BioCapital 1 operation
- Sanofi Ventures 1 operation
- Sectoral Asset Management 1 operation
- TPG Life Sciences Innovations 1 operation
- Vivo Capital 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States, Belgium.